Ofatumumab vs Rituximab in Pemphigus Vulgaris: Real-World Data
A 13-author real-world cohort study comparing ofatumumab versus rituximab in pemphigus vulgaris appears in the JID October 2026 supplement (Vol. 146, Issue 10).
Topic
Anti Cd20 Therapy
Topic
Anti Cd20 Therapy
Pemphigus Vulgaris Therapy Pipeline Expands Beyond Rituximab
A new EMJ review details how pemphigus vulgaris treatment is broadening beyond rituximab, with pipeline candidates targeting fast…